ME1 and cancer: To investigate the differential expression of ME1 across various human cancers and their corresponding paracancerous tissues, we utilized the TIMER2.0 platform to analyze RNA sequencing data from 33 cancers within The Cancer Genome Atlas (TCGA) (Figure 2A).